Picture of ReproCELL Incorporated logo

4978 — ReproCELL Incorporated News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Table: Reprocell - 9-MTH group results

Feb 12 (Reuters)- 
             Reprocell Incorporated 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to  
                Dec 31, 2025        Dec 31, 2024      Mar 31, 2026 
                   LATEST             YEAR-AGO           LATEST    
                   RESULTS             RESULTS          FORECAST   
  Sales             1.61                2.07              2.28     
                 (-22.2 pct)         (+16.4 pct)      (-23.4 pct)  
  Operating     loss 676 mln        loss 180 mln      loss 844 mln 
  Recurring     loss 455 mln         loss 33 mln      loss 574 mln 
  Net           loss 458 mln         loss 31 mln      loss 575 mln 
  EPS           loss 4.85 yen       loss 0.34 yen    loss 6.07 yen 
  Ann Div                                NIL              NIL      
  -Q2 div            NIL                 NIL                       
  -Q4 div                                NIL              NIL      
  
  NOTE - Reprocell Incorporated. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4978.T

Recent news on ReproCELL Incorporated

See all news